Stock Events

Merck KGAA 

$179.69
230
-$3.48-1.9% Monday 17:47

Statistics

Day High
185
Day Low
185
52W High
189.65
52W Low
143.46
Volume
138
Avg. Volume
676
Mkt Cap
24.09B
P/E Ratio
0
Dividend Yield
1.31%
Dividend
2.36

Upcoming

Dividends

1.31%Dividend Yield
10Y Growth
4.1%
5Y Growth
11.01%
3Y Growth
11.71%
1Y Growth
-2.68%

Earnings

15MayConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
1.94
2.21
2.47
2.73
Expected EPS
2.0472166565031795
Actual EPS
2.243226761913059

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MKGAF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Pharmaceuticals: Major
Health Technology
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.
Show more...
CEO
Stefan Oschmann
Employees
62345
Country
DE
ISIN
DE0006599905
WKN
000659990

Listings